Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. (2016)
Attributed to:
MICA: Investigation into the mechanisms that drive cough in health and disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2016-000148
PubMed Identifier: 28074135
Publication URI: http://europepmc.org/abstract/MED/28074135
Type: Journal Article/Review
Volume: 3
Parent Publication: BMJ open respiratory research
Issue: 1
ISSN: 2052-4439